Skip to content

MTVA

MetaVia Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.79
−2.99%
Ask drillr
  • Aug 6, 2026, 20:05 UTC

    MetaVia Inc. announced its financial results for the second quarter ended June 30, 2026.

  • Jun 8, 2026, 12:31 UTC

    MetaVia Inc. presented new late-breaking obesity and metabolic data at the ADA 2026 Scientific Sessions in New Orleans, Louisiana, supporting its DA-1726 and vanoglipel programs.